# Oral Ciclosporin for Colonic Release in Ulcerative Colitis (CyCol™)

> **NCT01033305** · PHASE2 · COMPLETED · sponsor: **Sigmoid Pharma** · enrollment: 118 (actual)

## Conditions studied

- Mild to Moderate Ulcerative Colitis

## Interventions

- **DRUG:** CyCol™
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01033305
- **Lead sponsor:** Sigmoid Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-03
- **Primary completion:** 2011-08
- **Final completion:** 2011-09
- **Target enrollment:** 118 (ACTUAL)
- **Last updated:** 2012-04-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01033305

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01033305, "Oral Ciclosporin for Colonic Release in Ulcerative Colitis (CyCol™)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01033305. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*